annual working capital:
$472.97M+$21.22M(+4.70%)Summary
- As of today (September 16, 2025), RARE annual working capital is $472.97 million, with the most recent change of +$21.22 million (+4.70%) on December 31, 2024.
- During the last 3 years, RARE annual working capital has fallen by -$202.27 million (-29.95%).
- RARE annual working capital is now -57.22% below its all-time high of $1.11 billion, reached on December 31, 2020.
Performance
RARE Working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly working capital:
$426.54M+$19.06M(+4.68%)Summary
- As of today (September 16, 2025), RARE quarterly working capital is $426.54 million, with the most recent change of +$19.06 million (+4.68%) on June 30, 2025.
- Over the past year, RARE quarterly working capital has dropped by -$265.23 million (-38.34%).
- RARE quarterly working capital is now -61.42% below its all-time high of $1.11 billion, reached on December 31, 2020.
Performance
RARE quarterly working capital Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Working capital Formula
Working Capital = Current Assets − Current Liabilities
RARE Working capital Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +4.7% | -38.3% |
| 3 y3 years | -29.9% | -6.8% |
| 5 y5 years | -36.7% | -37.9% |
RARE Working capital Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -29.9% | +4.7% | -45.7% | +23.6% |
| 5 y | 5-year | -57.2% | +4.7% | -61.4% | +23.6% |
| alltime | all time | -57.2% | +4651.6% | -61.4% | +499.0% |
RARE Working capital History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $426.54M(+4.7%) |
| Mar 2025 | - | $407.49M(-13.8%) |
| Dec 2024 | $472.97M(+4.7%) | $472.97M(-8.1%) |
| Sep 2024 | - | $514.60M(-25.6%) |
| Jun 2024 | - | $691.77M(+97.4%) |
| Mar 2024 | - | $350.39M(-22.4%) |
| Dec 2023 | $451.75M(-27.5%) | $451.75M(+30.9%) |
| Sep 2023 | - | $345.21M(-24.6%) |
| Jun 2023 | - | $457.76M(-16.5%) |
| Mar 2023 | - | $548.16M(-12.0%) |
| Dec 2022 | $622.69M(-7.8%) | $622.69M(-20.7%) |
| Sep 2022 | - | $785.31M(+71.5%) |
| Jun 2022 | - | $457.91M(-15.2%) |
| Mar 2022 | - | $540.29M(-20.0%) |
| Dec 2021 | $675.24M(-38.9%) | $675.24M(-5.0%) |
| Sep 2021 | - | $710.95M(-13.6%) |
| Jun 2021 | - | $822.42M(-12.9%) |
| Mar 2021 | - | $943.89M(-14.6%) |
| Dec 2020 | $1.11B(+47.9%) | $1.11B(+64.8%) |
| Sep 2020 | - | $670.82M(-2.3%) |
| Jun 2020 | - | $686.31M(-1.6%) |
| Mar 2020 | - | $697.46M(-6.7%) |
| Dec 2019 | $747.72M | $747.72M(+42.9%) |
| Sep 2019 | - | $523.18M(-16.2%) |
| Jun 2019 | - | $624.42M(-13.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | $720.01M(+60.8%) |
| Dec 2018 | $447.64M(+125.4%) | $447.64M(-10.6%) |
| Sep 2018 | - | $500.80M(-7.0%) |
| Jun 2018 | - | $538.69M(+2.8%) |
| Mar 2018 | - | $524.00M(+163.9%) |
| Dec 2017 | $198.57M(-41.8%) | $198.57M(-39.2%) |
| Sep 2017 | - | $326.64M(-8.5%) |
| Jun 2017 | - | $357.12M(-9.1%) |
| Mar 2017 | - | $392.93M(+15.1%) |
| Dec 2016 | $341.44M(-19.1%) | $341.44M(-6.8%) |
| Sep 2016 | - | $366.35M(-3.4%) |
| Jun 2016 | - | $379.10M(-5.3%) |
| Mar 2016 | - | $400.35M(-5.2%) |
| Dec 2015 | $422.29M(+133.4%) | $422.29M(-3.1%) |
| Sep 2015 | - | $435.97M(+39.1%) |
| Jun 2015 | - | $313.49M(-6.8%) |
| Mar 2015 | - | $336.27M(+85.9%) |
| Dec 2014 | $180.90M(+266.9%) | $180.90M(-7.5%) |
| Sep 2014 | - | $195.67M(+31.4%) |
| Jun 2014 | - | $148.96M(-8.5%) |
| Mar 2014 | - | $162.82M(+230.2%) |
| Dec 2013 | $49.30M(-40.8%) | $49.30M(-146.1%) |
| Sep 2013 | - | -$106.90M(-256.1%) |
| Jun 2013 | - | $68.47M(-17.8%) |
| Dec 2012 | $83.26M(+736.4%) | $83.26M |
| Dec 2011 | $9.95M | - |
FAQ
- What is Ultragenyx Pharmaceutical Inc. annual working capital?
- What is the all time high annual working capital for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. annual working capital year-on-year change?
- What is Ultragenyx Pharmaceutical Inc. quarterly working capital?
- What is the all time high quarterly working capital for Ultragenyx Pharmaceutical Inc.?
- What is Ultragenyx Pharmaceutical Inc. quarterly working capital year-on-year change?
What is Ultragenyx Pharmaceutical Inc. annual working capital?
The current annual working capital of RARE is $472.97M
What is the all time high annual working capital for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high annual working capital is $1.11B
What is Ultragenyx Pharmaceutical Inc. annual working capital year-on-year change?
Over the past year, RARE annual working capital has changed by +$21.22M (+4.70%)
What is Ultragenyx Pharmaceutical Inc. quarterly working capital?
The current quarterly working capital of RARE is $426.54M
What is the all time high quarterly working capital for Ultragenyx Pharmaceutical Inc.?
Ultragenyx Pharmaceutical Inc. all-time high quarterly working capital is $1.11B
What is Ultragenyx Pharmaceutical Inc. quarterly working capital year-on-year change?
Over the past year, RARE quarterly working capital has changed by -$265.23M (-38.34%)